| Literature DB >> 35531578 |
Yikang Zhu1, Lihua Xu1, Qian Guo1, Tianhong Zhang1, Xiaochen Hu2, Paul Enck3, Jijun Wang1,4,5, Chunbo Li1,4,5.
Abstract
Background: Eye movement abnormality in schizophrenia has been studied for several decades. However, patient differences in eye movements across phases of schizophrenia from eye-tracking studies have not been well documented. Aims: This pilot study used eye-tracking technology to investigate attentive bias towards interpersonal communication information across different clinical phases of schizophrenia.Entities:
Keywords: Behavioural Research; Schizophrenia
Year: 2022 PMID: 35531578 PMCID: PMC9016392 DOI: 10.1136/gpsych-2021-100699
Source DB: PubMed Journal: Gen Psychiatr ISSN: 2517-729X
Figure 1The flowchart for the participant recruitment. CHR, clinical high-risk; DSM-IV-IR, Diagnostic and Statistical Manual of Mental disorders-Fourth Edition, Text Revision; FEZ, first-episode; HCs, healthy controls; M.I.N.I., Mini-International Neuropsychiatric Interview; SCID-I/P, Structural Clinical Interview for DSM-IV-TR, Patient's version; SD, standard deviation; SIPS, Structured Interview for Prodromal Symptoms; SOPS, Scale of Prodromal Syndromes.
Figure 2The graph depicts the experimental procedure that is fixed for each time with the sequence of cross fixation (1000 ms) and pictures (4000 ms). Two of the three types of pictures were presented in pairs on 24 trials linked between cross fixation.
ANCOVA results of gaze measures with age and education as covariates, mean (SD)
| Variables | HC | CHR | FEZ | Chronic | F | P value |
| Initial fixation duration (ratios) | ||||||
| Mode I | 0.17 (0.49) | 0.21 (0.47) | 0.21 (0.55) | 0.18 (0.42) | 0.121 | 0.948 |
| Mode II | 0.21 (0.50) | 0.17 (0.39) | 0.29 (0.61) | 0.16 (0.33) | 0.845 | 0.470 |
| Mode III | 0.31 (0.36) | 0.36 (0.42) | 0.31 (0.46) | 0.13 (0.34) | 3.269 | 0.022* |
| Total gaze duration (ratios) | ||||||
| Mode I | 1.34 (1.14) | 1.69 (1.55) | 1.69 (1.55) | 1.48 (1.45) | 0.962 | 0.411 |
| Mode II | 1.65 (1.19) | 1.53 (1.23) | 1.39 (1.30) | 1.65 (1.62) | 0.532 | 0.661 |
| Mode III | 0.15 (0.32) | 0.25 (0.55) | 0.18 (0.35) | 0.35 (0.59) | 2.097 | 0.101 |
Mode I: (Duration Picture 2–Duration Picture 1)/Duration Picture 1.
Mode II: (Duration Picture 3–DurationPicture 1)/Duration Picture 1.
Mode III: (Duration Picture 3–DurationPicture 2)/Duration Picture 2.
*p<0.05.
ANCOVA, analysis of covariance; CHR, clinical high-risk; Chronic, chronically ill patient group; FEZ, first-episode; HC, healthy control; SD, Standard Deviation.
Demographic and clinical characteristics, mean(SD)
| Variables | HC | CHR | FEZ | Chronic | F/t/χ2 | P value |
| Age (years) | 23.09 (3.46) | 23.76 (4.46) | 24.53 (4.59) | 25.10 (3.67) | 2.586 | 0.054 |
| Gender (M/F), n | 33/41 | 40/38 | 46/22 | 24/15 | 8.744 | 0.033* |
| Education (years) | 13.27 (2.34) | 13.26 (2.83) | 13.04 (2.92) | 13.38 (3.17) | 0.149 | 0.930 |
| Duration of illness (months) | – | – | – | 49.79 (36.48) | – | – |
| PANSS total score | – | – | 79.44 (14.80) | 74.23 (20.79) | 1.507 | 0.135 |
| PANSS positive symptom | – | – | 19.31 (5.94) | 19.46 (7.58) | −0.115 | 0.909 |
| PANSS negative symptom | – | – | 16.68 (7.81) | 19.15 (8.80) | −1.477 | 0.143 |
| PANSS general psychopathology | – | – | 40.94 (7.09) | 35.62 (9.75) | 3.171 | 0.002** |
| SIPS/SOPS | – | 36.19 (10.04) | – | – | – | – |
| MCCB total score (T score) | 54.26 (6.14) | 47.48 (7.77) | 43.02 (8.54) | – | 32.479 | <0.001** |
| MCCB social cognition (T score) | 36.57 (6.57) | 35.71 (7.96) | 31.98 (7.29) | – | 6.305 | 0.002** |
Sample size (PANSS): FEZ=62, Chronic=39; (MCCB): HC=61, CHR=69, FEZ=52; (MCCB social cognition): HC=61, CHR=70, FEZ=54.
*p<0.05, **p<0.01.
CHR, clinical high-risk; Chronic, chronically ill patient group; F, female; FEZ, first-episode; HC, healthy control; M, male; MCCB, Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery; PANSS, Positive and Negative Syndrome Scale; SD, Standard Deviation; SIPS/SOPS, Structured Interview for Prodromal Symptoms and the Scale of Prodromal Syndromes.
Figure 3Chronically ill patients showed a smaller ratio of initial fixation duration compared with FEZ patients (p=0.030), CHR patients (p=0.003) and HCs (p=0.009), as indicated by the result of post hoc analysis. This means that chronically ill patients invested less attentive processing resources on pictures with people communicating, while HCs, by contrast, invested more. CHR, clinical high-risk; FEZ, first-episode; HCs, healthy controls.
Figure 4Spearman’s correlation yielded negative correlation between SIPS and the ratio of initial fixation duration between type 1 and type 2 pictures in CHR patients (r=−0.35, p=0.002). CHR, clinical high-risk; SIPS, Structured Interview for Prodromal Symptoms.
Figure 5Spearman’s correlation revealed negative correlation between PANSS negative symptoms and the ratio of initial fixation duration between type 1 and type 3 pictures in chronically ill patients (r=−0.33, p=0.037) but not in FEZ patients (r=−0.14, p=0.266). FEZ, first-episode; PANSS, Positive and Negative Syndrome Scale.